H.P. Acthar Gel

H.P. Acthar Gel is a brand name of corticotropin, approved by the FDA in the following formulation(s):

H.P. ACTHAR GEL (corticotropin - injectable; injection)

• 
  Manufacturer: QUESTCOR PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 80 UNITS/ML ^[RLD]

Has a generic version of H.P. Acthar Gel been approved?

No. There is currently no therapeutically equivalent version of H.P. Acthar Gel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of H.P. Acthar Gel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with H.P. Acthar Gel.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 15, 2017 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• HP Acthar Gel Consumer Information (Wolters Kluwer)
• Acthar Gel, H.P. Consumer Information (Cerner Multum)
• H.P. Acthar Gel AHFS DI Monographs (ASHP)
• Corticotropin Gel Consumer Information (Wolters Kluwer)
• Corticotropin Consumer Information (Cerner Multum)
• H.P. Acthar Advanced Consumer Information (Micromedex)
• Corticotropin Injection Advanced Consumer Information (Micromedex)
• Corticotropin AHFS DI Monographs (ASHP)
• Corticotropin (Anti-inflammatory) AHFS DI Monographs (ASHP)